Evidence map›Paper›PMID 42475028›Full record

ArticleInternational forum of allergy & rhinology2026

Persistent Smell and Taste Disorders in the Post-COVID-19 Pandemic Era: A Cross-National Study of Prevalence and Quality of Life in the UK and the USA.

Umar Rehman, Zi Jian Lau, Carl Philpott, Valerie J Lund, Nicholas Eynon-Lewis, Jens Peter Klussmann, R Peter Manes, Benjamin L Judson, Adam J Kimple, Wendell G Yarbrough and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International forum of allergy & rhinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Umar RehmanDivision of Surgery and Interventional Science, University College London, London, UK.
Zi Jian LauDivision of Surgery and Interventional Science, University College London, London, UK.
Carl PhilpottNorwich Medical School, University of East Anglia, Norwich, UK.ORCID https://orcid.org/0000-0002-1125-3236
Valerie J LundRoyal National Ear, Nose and Throat Hospital, University College London Hospitals NHS Foundation Trust, London, UK.
Nicholas Eynon-LewisDepartment of ENT, The Royal London Hospital, London, UK.
Jens Peter KlussmannMedical Faculty, Department of Otorhinolaryngology, Head and Neck Surgery, University of Cologne, Cologne, Germany.
R Peter ManesDepartment of Surgery, Section of Otolaryngology and Head and Neck Surgery, Yale School of Medicine, New Haven, Connecticut, USA.
Benjamin L JudsonDepartment of Surgery, Section of Otolaryngology and Head and Neck Surgery, Yale School of Medicine, New Haven, Connecticut, USA.
Adam J KimpleDepartment of Otolaryngology and Head and Neck Surgery, University of North Carolina, Chapel Hill, North Carolina, USA.
Wendell G YarbroughDepartment of Otolaryngology and Head and Neck Surgery, University of North Carolina, Chapel Hill, North Carolina, USA.
Jayakar V NayakDepartment of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, California, USA.ORCID https://orcid.org/0000-0003-4454-0861
Peter H HwangDepartment of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, California, USA.ORCID https://orcid.org/0000-0002-0786-4675
Zara M PatelDepartment of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, California, USA.ORCID https://orcid.org/0000-0003-2072-982X
Matt LechnerDivision of Surgery and Interventional Science, University College London, London, UK.ORCID https://orcid.org/0000-0002-7123-0773

Funding

Head and Neck Cancer and Rhinology Research TrustRosetrees Trust OoR2021∖100008University of North CarolinaYale School of Medicine
6 · The paper itself

Abstract

key pointsAnosmia/hyposmia affected 14.8%-19.6% of participants in the UK and the USA in the post-pandemic era. Since symptom onset, 37.1%-48.8% of affected participants reported no improvement, while 15.3%-17.6% reported worsening symptoms. Anosmia/hyposmia remains strongly associated with reduced quality of life across both countries. Among respondents reporting anosmia or hyposmia, a high proportion (88.8%-93.5%) also experienced concurrent parosmia.

Indexed as

AnosmiaCOVID-19Olfaction DisordersQuality of LifeTaste DisordersAdultAgedFemaleHumansMaleMiddle AgedPandemicsPrevalenceUnited KingdomUnited StatesCOVID‐19quality of lifesmell and taste disorders

Identifiers

PMID42475028
PMCPMC13544447

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.